Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
Open Access
- 14 February 2009
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 16 (5), 1112-1121
- https://doi.org/10.1245/s10434-009-0334-7
Abstract
We sought to determine the significance of Ki-67, one of the tumor cell proliferation markers, as a useful prognostic factor in early breast cancer.Keywords
This publication has 35 references indexed in Scilit:
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patientsBritish Journal of Cancer, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- Ki‐67 expression in breast carcinomaCancer, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Ki-67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosisInternational Journal of Cancer, 1997
- The important prognostic value of Ki-67 expression as determined by image analysis in breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991